Email: sdraytan@163.com Tel: 0086-137-3096-1137
Email: sdraytan@163.com Tel: 0086-137-3096-1137
In the global medical‑device trade landscape, cost‑performance ratio, consistent quality and dependable after‑sales support constitute the three most critical demands of overseas medical institutions and traders.
As an enterprise with years of in‑depth expertise in medical‑device export, we focus on three core product lines: patient monitors, electrocardiographs and X‑ray equipment. We have built a strong presence across global healthcare markets, serving medical institutions, distributors and purchasers in more than 100 countries and regions covering Asia, Africa, Latin America, Europe and beyond.
Differentiated from the extensive export model prevalent in the industry, we consistently adhere to our global‑market principles: controllable production, traceable quality and accessible services. Instead of winning market share through marketing gimmicks, we build our global reputation with solid production capacity, field‑proven product quality and practical localised services. Below, we illustrate our robust global‑market capabilities with authentic statistics and real‑world overseas project cases.
Medical devices are directly linked to clinical diagnosis and treatment safety. Standardised, intelligent and large‑scale production is the cornerstone of consistent product output and on‑time fulfilment of overseas orders.
Moving away from conventional extensive production practices, we have constructed fully‑integrated intelligent workshops covering the full product lines of patient monitors, electrocardiographs and X‑ray equipment. The entire workflow — from procurement of core components and modular assembly to complete‑machine commissioning and finished‑product packaging — is independently managed in‑house. This effectively mitigates common industry pitfalls associated with outsourced manufacturing, such as inconsistent quality control and delivery delays.
Sufficient and Stable Production Capacity: Three dedicated production lines for our flagship products operate at full capacity on a steady basis. Monthly output reaches over 800 patient monitors, more than 500 electrocardiographs and over 120 sets of medical X‑ray equipment. We flexibly accommodate small‑and‑medium‑sized custom orders as well as large‑scale overseas group‑procurement contracts, with smooth delivery even during peak seasons.
Superior Delivery Performance: Ready‑stock orders are shipped within 72 hours. Orders requiring custom parameter configuration are fulfilled within 7‑10 working days. Our on‑time delivery rate for overseas orders in the past year stands at 100 %. We have collaborated with more than 300 distributors worldwide without a single complaint about delayed deliveries.
Self‑Reliant Supply Chain: Long‑term strategic partnerships have been established for core‑component sourcing. Core parts are supplied via a dual‑track approach combining in‑house R&D and rigorously selected external suppliers. This buffers against global supply‑chain volatility and shortens the lead‑time for spare‑parts supply for equipment repairs by 40 %.
For medical‑device exports, quality is the fundamental foundation for market survival. Countries and regions enforce stringent market‑access requirements regarding accuracy, stability and safety of medical devices. This is especially true for patient‑monitoring, electrocardiography and X‑ray imaging equipment, whose performance directly affects diagnostic outcomes and permits zero negligence.
Guided by the quality‑control philosophy of “zero defects, zero hidden hazards”, we strictly comply with the ISO 13485 Medical Device Quality Management System. Our complete product portfolio has obtained authoritative international certifications including CE (EU) and FDA, fully meeting mainstream global market‑access requirements. Every unit exported undergoes stringent international‑standard verification and real‑world clinical validation.
End‑to‑End Testing Regime: A four‑tier inspection mechanism is implemented: incoming‑material sampling inspection, in‑process production patrol inspection, full‑scale finished‑product testing and final pre‑shipment audit. Each individual device undergoes more than 20 inspection procedures. Specialised rigorous tests are conducted focusing on patient‑monitor data accuracy, electrocardiograph waveform stability, as well as radiation safety and imaging clarity of X‑ray systems.
Industry‑Leading Product Failure Rate: The overall repair rate of our exported devices over the past three years is as low as 0.3 %, far below the industry‑average level of 1.2 %. The failure rate of patient monitors and electrocardiographs under routine clinical use is close to zero.
Full‑Coverage Quality Traceability: Every exported device carries a unique traceability code. Production parameters, test records and factory‑release information are fully traceable for verification by overseas customers and regulatory authorities, ensuring both compliance and safety.
For many overseas buyers of Chinese‑manufactured medical devices, the primary concerns are not price or product quality, but slow after‑sales response, lengthy repair cycles and difficult technical communication. Each day of equipment downtime disrupts clinical workflows and brings direct economic losses to healthcare facilities.
With deep insights into the pain points of overseas clients gained through years of foreign‑trade practice, we reject the traditional export mindset that “sales mark the end of service”. Instead, we operate a comprehensive after‑sales system featuring rapid online response, overseas on‑site support and lifelong technical enablement, so that overseas customers can purchase and operate our equipment with complete peace of mind.
Rapid‑Response Mechanism: A 7×24 multilingual after‑sales hotline is available with customer‑service specialists proficient in English, Spanish, French and other languages. Inquiries from overseas clients receive a response within 10 minutes, and common faults are resolved online within 30 minutes.
Effective On‑Site Support: Partner‑operated service stations are deployed in key markets across Southeast Asia, Africa and Latin America. For core regions, on‑site maintenance is available within 48 hours in case of equipment breakdowns, with priority spare‑parts allocation and replacement to minimise equipment downtime.
Lifelong Empowerment Services: All partner customers enjoy free equipment‑operation training, remote technical guidance and lifetime system‑upgrade services. We deliver more than 200 technical‑training sessions for overseas clients annually, achieving an after‑sales customer‑satisfaction rate of 99.6 %.
In March 2025, an X‑ray device at a partner hospital in Latin America suffered sudden imaging anomalies amid a peak‑patient‑volume period, severely disrupting outpatient diagnostic workflows. The customer reached out for urgent support.
Upon receiving the request, our after‑sales team immediately activated the priority‑response protocol. Multilingual engineers connected remotely, quickly diagnosed the root cause and guided on‑site staff through preliminary debugging to restore provisional functionality of the equipment. Meanwhile, spare parts and field engineers were dispatched from the nearest overseas service station. On‑site arrival was achieved within 36 hours for full‑component replacement, complete‑machine calibration and precision verification. The equipment was fully restored to standard operating conditions.
Such efficient, professional and thoughtful after‑sales support eliminated the client’s misgivings about slow after‑sales support for Chinese‑made equipment. The hospital subsequently signed an exclusive annual procurement agreement and became one of our core strategic partners in the Latin‑American market.
Medical‑device global expansion is never a race driven by cut‑throat price competition. What truly counts is stable production capacity, dependable product quality and sustainable after‑sales services.
We build reliable delivery capability through standardised manufacturing, safeguard clinical safety with rigorous quality assurance, and empower global clients via comprehensive after‑sales solutions. We always back our offerings with tangible production capacity, verified performance data and proven real‑world cases, and reject inflated capability claims and superficial service practices.
Going forward, we will continue to specialise in patient monitors, electrocardiographs and X‑ray systems. With higher‑calibre products, more complete service offerings and flexible cooperation models, we will support the upgrade of medical facilities worldwide. High‑quality Chinese‑manufactured medical devices will keep reaching every corner of the globe where they are needed.
Global Cooperation Opportunities Are Open for Negotiation
二维码
